{"id":3830,"date":"2025-08-12T19:35:00","date_gmt":"2025-08-13T00:35:00","guid":{"rendered":"https:\/\/mickeylieberman.com\/parkinsons\/?p=3830"},"modified":"2025-04-25T13:37:27","modified_gmt":"2025-04-25T18:37:27","slug":"parkinsons-disease-symptoms-diagnosis-and-treatment-overview","status":"publish","type":"post","link":"https:\/\/mickeylieberman.com\/parkinsons\/parkinsons-disease-symptoms-diagnosis-and-treatment-overview\/","title":{"rendered":"Parkinson&#8217;s Disease Symptoms, Diagnosis And Treatment Overview"},"content":{"rendered":"<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Parkinson&#8217;s Disease Symptoms<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Regardless of all the research that has looked into Parkinson&#8217;s, it&#8217;s a disease without a cure at this point. Parkinson&#8217;s is a non-contagious, degenerative brain condition connected with a high rate of cellular loss of dopamine-secreting cells.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\"> A particular problem is the fact that a defined biomarker for the condition has still not been found. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">This means that diagnosing the condition can only be accomplished through observing a person&#8217;s symptoms and by a process of elimination, through ruling out other disorders whose symptoms resemble Parkinson&#8217;s. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">This may include discounting numerous other neurological conditions such as Creutzfeldt-Jakob disease, brain tumors, Alzheimer&#8217;s disease, or psychiatric disorders, medication side effects, and atypical Parkinsonian conditions, including Multiple System Atrophy.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Parkinson&#8217;s early signs may often be overlooked or passed off as being brought about by a range of minor maladies. For instance, the person may feel weary, aching, and generally &#8216;out of sorts&#8217;; even a doctor during this stage may not recognize Parkinson&#8217;s as a possible candidate. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">It is once signs or symptoms persist and become more apparent that investigations are usually instigated to unravel the underlying cause.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Diagnosis initially should involve discounting the possibility of bacterial or viral infection, diabetes, or glandular conditions, and the possibility of cancer through carrying out blood and urine tests. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">If the person should begin to encounter some of the more common signs or symptoms of Parkinson&#8217;s disease, they will probably be referred to a specialist for further assessment. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Diagnosis by a neurologist will involve reviewing the individual&#8217;s medical history, undertaking a neurological check-up up and conducting various blood, urine, and brain scan tests. Features of Parkinson&#8217;s disease include a lack of dopamine in the brain and reduced norepinephrine levels.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The classic symptoms of Parkinson&#8217;s disease include slow movements, increasing muscle rigidity, tremor, and at the advanced stages of the condition, balance problems. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">A variety of other symptoms can develop, such as issues related to do with sleep patterns, speech, urination problems, or constipation, changes in perception, and diminished unconscious acts, including the vacant stare or Parkinson&#8217;s mask. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Additionally, the person&#8217;s mental well-being is often affected, manifesting in an increased risk of anxiety, antisocial behavior, and depression. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Cognitive disturbances that affect concentration, mental agility, and visuospatial awareness affect a notable proportion of patients, and approximately 20% will go on to develop Parkinson&#8217;s dementia.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Even though the underlying mechanism and cause of the condition continues to be not fully understood, factors such as age, gender, race, genetics, and environmental variables, including pesticides, herbicides, and other toxins, viruses, and bacteria may all prove associated to some extent regarding the chance of developing the condition. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">We can declare that although the data is far from complete right now, and research does sometimes deviate in conclusion, it&#8217;s a disease that is complex and whose risk goes up with age. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">On this note and rather unexpectedly, it would appear people with high cholesterol or who smoke or drink coffee regularly have a lower risk of going on to develop Parkinson&#8217;s. Also, Parkinson&#8217;s diagnosis is comparatively unknown in the extreme old age category over age one hundred.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">A variety of systems have been formulated to categorize the development of Parkinson&#8217;s.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Since the late nineteen-eighties, the three that are in most widespread use include the Hoelm and Yahr, Schwab and England, and the Unified Parkinson&#8217;s Disease Rating Scale. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">As the disease advances, involuntary movements become progressively problematic. Although not terminal in itself, death is usually connected with secondary complications from strokes, falls, septicemia, and pneumonia.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Medical care of Parkinson&#8217;s disease involves continual monitoring to adapt to the changing symptoms and to control these effectively. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The use of pharmaceuticals may include Levodopa, Anticholinergenics, COMT inhibitors, Dopamine Agonists, as well as NMDA blockers, MAO B Inhibitors, and possibly new and somewhat developmental drugs for the condition. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">In addition, an overall process that features various therapies and nutritional considerations may be employed, as well as the possibility of deep brain stimulation through a surgical implant may be considered based on medical necessity.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Research into Parkinson&#8217;s continues on a worldwide basis, and significant advances have been made over the last decade. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Searching for a biomarker moves on apace, as does growing interest in looking at the cellular level involving stem cell therapy and genetic engineering. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">A variety of new drugs are undergoing trials, and re-evaluation of existing drugs and therapies to boost their effectiveness continues on an ongoing basis. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">If one considers that we&#8217;re entering a period of an extraordinary increase in the global population size, a constantly upward path for life expectancy, plus an increasingly aged population, the number of Parkinson&#8217;s disease patients will increase greatly in the foreseeable future. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Apart from the impact of the condition on a personal level as experienced by the patients, carers, and loved ones of Parkinson&#8217;s disease, there will be an ever-increasing financial cost to the taxpayer. <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The motivation for developing a cure for Parkinson&#8217;s disease has and thus never been more urgent.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">A resource for those experiencing or having to deal with Parkinson&#8217;s and includes info on the symptoms, risk factors and statistics, stages, causes, prognosis, treatments and therapies, and current news about the condition.<br \/>\n<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Parkinson&#8217;s Disease Symptoms Regardless of all the research that has looked into Parkinson&#8217;s, it&#8217;s a disease without a cure at this point. Parkinson&#8217;s is a&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"slim_seo":{"title":"Parkinson's Disease Symptoms, Diagnosis And Treatment Overview - Parkinson&#039;s Disease","description":"Parkinson's Disease Symptoms Regardless of all the research that has looked into Parkinson's, it's a disease without a cure at this point. Parkinson's is a non-"},"_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3830","post","type-post","status-publish","format-standard","hentry","category-parkinsons","wpcat-1-id"],"_links":{"self":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/posts\/3830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/comments?post=3830"}],"version-history":[{"count":0,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/posts\/3830\/revisions"}],"wp:attachment":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/media?parent=3830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/categories?post=3830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/tags?post=3830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}